Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-HIV reverse transcriptase plant polyphenolic natural products with in silico inhibitory properties on seven non-structural proteins vital in SARS-CoV-2 pathogenesis
Von Novi O. de Leon, Joe Anthony Manzano, Delfin Yñigo H. Pilapil, et al.
Journal of Genetic Engineering and Biotechnology (2021) Vol. 19, Iss. 1, pp. 104-104
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

A systematic review of natural products for skin applications: Targeting inflammation, wound healing, and photo-aging
Andreia S. Fernandes, Pedro Rodrigues, Manuela Pintado, et al.
Phytomedicine (2023) Vol. 115, pp. 154824-154824
Open Access | Times Cited: 90
Attenuation of Lipopolysaccharide-Induced Inflammatory Responses through Inhibition of the NF-κB Pathway and the Increased NRF2 Level by a Flavonol-Enriched n-Butanol Fraction from Uvaria alba
Kin Israel Notarte, Mark Tristan J. Quimque, Imee Macaranas, et al.
ACS Omega (2023) Vol. 8, Iss. 6, pp. 5377-5392
Open Access | Times Cited: 47
Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Chemical Reviews (2022) Vol. 122, Iss. 13, pp. 11287-11368
Open Access | Times Cited: 56
Isolation of anticancer bioactive secondary metabolites from the sponge-derived endophytic fungi Penicillium sp. and in-silico computational docking approach
Kumaravel Kaliaperumal, Limbadri Salendra, Yonghong Liu, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 28
Anti-COVID-19 Potential of Ellagic Acid and Polyphenols of Punica granatum L.
Ralitza Alexova, Simona Alexandrova, Stela Dragomanova, et al.
Molecules (2023) Vol. 28, Iss. 9, pp. 3772-3772
Open Access | Times Cited: 18
Advances in bioinformatic methods for the acceleration of the drug discovery from nature
Magdalena Maciejewska‐Turska, Milen I. Georgiev, Guoyin Kai, et al.
Phytomedicine (2025) Vol. 139, pp. 156518-156518
Closed Access
Virtual Combinatorial Library Screening of Quinadoline B Derivatives against SARS-CoV-2 RNA-Dependent RNA Polymerase
Simone Brogi, Mark Tristan J. Quimque, Kin Israel Notarte, et al.
Computation (2022) Vol. 10, Iss. 1, pp. 7-7
Open Access | Times Cited: 22
Identifying non-nucleoside inhibitors of RNA-dependent RNA-polymerase of SARS-CoV-2 through per-residue energy decomposition-based pharmacophore modeling, molecular docking, and molecular dynamics simulation
Shahkaar Aziz, Muhammad Waqas, Tapan Kumar Mohanta, et al.
Journal of Infection and Public Health (2023) Vol. 16, Iss. 4, pp. 501-519
Open Access | Times Cited: 12
Deciphering antiviral efficacy of malaria box compounds against malaria exacerbating viral pathogens- Epstein Barr virus and SARS-CoV-2, an in silico study
Omkar Indari, Ajit Kumar Singh, Deeksha Tiwari, et al.
Medicine in Drug Discovery (2022) Vol. 16, pp. 100146-100146
Open Access | Times Cited: 21
The naturally‐derived alkaloids as a potential treatment for COVID‐19: A scoping review
Bárbara Longhini Gonzalez, Natalia Castelhano de Oliveira, Mariane Roberta Ritter, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 7, pp. 2686-2709
Open Access | Times Cited: 20
Globospiramine from Voacanga globosa Exerts Robust Cytotoxic and Antiproliferative Activities on Cancer Cells by Inducing Caspase-Dependent Apoptosis in A549 Cells and Inhibiting MAPK14 (p38α): In Vitro and Computational Investigations
Joe Anthony Manzano, Elian Angelo Abellanosa, Jose Paolo Aguilar, et al.
Cells (2024) Vol. 13, Iss. 9, pp. 772-772
Open Access | Times Cited: 3
Myxobacterial depsipeptide chondramides interrupt SARS-CoV-2 entry by targeting its broad, cell tropic spike protein
Rey Arturo T. Fernandez, Mark Tristan J. Quimque, Kin Israel Notarte, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 22, pp. 12209-12220
Open Access | Times Cited: 20
A Comprehensive Update of Various Attempts by Medicinal Chemists to Combat COVID-19 through Natural Products
Ayesha Rafiq, Tooba Jabeen, Sana Aslam, et al.
Molecules (2023) Vol. 28, Iss. 12, pp. 4860-4860
Open Access | Times Cited: 8
Tetrahydrobisbenzylisoquinoline alkaloids from Phaeanthus ophthalmicus inhibit target enzymes associated with type 2 diabetes and obesity
Joe Anthony Manzano, Lloyd Christian J. Llames, Allan Patrick G. Macabeo
Journal of Applied Pharmaceutical Science (2023)
Open Access | Times Cited: 7
Polyphenolic Natural Products Active In Silico Against SARS-CoV-2 Spike Receptor Binding Domains and Non-structural Proteins - A Review
Allan Patrick G. Macabeo, Mark Tristan J. Quimque, Kin Israel Notarte, et al.
Combinatorial Chemistry & High Throughput Screening (2021) Vol. 26, Iss. 3, pp. 459-488
Closed Access | Times Cited: 15
Urtica dioica agglutinin (UDA) as a potential candidate for inhibition of SARS-CoV-2 Omicron variants: In silico prediction and experimental validation
Fatemeh Sabzian‐Molaei, Seyedrafi Hosseini, Atefeh Alipour, et al.
Phytomedicine (2023) Vol. 111, pp. 154648-154648
Open Access | Times Cited: 5
Mycobacterium tuberculosis Inhibitors Based on Arylated Quinoline Carboxylic Acid Backbones with Anti-Mtb Gyrase Activity
Mark Tristan J. Quimque, Adrian D. Go, Justin Allen K. Lim, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11632-11632
Open Access | Times Cited: 5
Essential oils for COVID-19 management: A systematic review of randomized controlled trials
Teuku F. Duta, Diva Rayyan Rizki, Agnia Purnama, et al.
Narra X (2023) Vol. 1, Iss. 2
Open Access | Times Cited: 5
Looking for SARS-CoV-2 Therapeutics Through Computational Approaches
Marian Vincenzi, Flavia Anna Mercurio, Marilisa Leone
Current Medicinal Chemistry (2022) Vol. 30, Iss. 28, pp. 3158-3214
Closed Access | Times Cited: 9
In Silico Assessment of the Role of Iridoid in the Treatment of Zika and Influenza Virus Infection
Supriyo Saha, Prinsa Prinsa, Vikash Jakhmola, et al.
The Philippine journal of science (2023) Vol. 152, Iss. 5
Open Access | Times Cited: 4
Voacanga globosa Spirobisindole Alkaloids Exert Antiviral Activity in HIV Latently Infected Cell Lines by Targeting the NF-κB Cascade: In Vitro and In Silico Investigations
Ma. de Jesus, Allan Patrick G. Macabeo, John Donnie A. Ramos, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 1078-1078
Open Access | Times Cited: 6
Computationally Repurposed Natural Products Targeting SARS-CoV-2 Attachment and Entry Mechanisms
Mark Tristan J. Quimque, Kin Israel Notarte, Von Novi O. de Leon, et al.
Springer eBooks (2022), pp. 505-537
Closed Access | Times Cited: 6
In Silico Potentials of Alpinia galanga Constituents against Human Placental Aromatase Vital in Postmenopausal Estrogen-dependent Breast Cancer Pathogenesis
Joe Anthony Manzano, Cecil Laurence Cruz, Mark Tristan J. Quimque, et al.
The Philippine journal of science (2022) Vol. 151, Iss. 6A
Open Access | Times Cited: 6
Computer-aided Drug Discovery Approaches in the Identification of Natural Products against SARS-CoV-2: A Review
Mariana Martinelli Junqueira Ribeiro
Current Computer - Aided Drug Design (2023) Vol. 20, Iss. 4, pp. 313-324
Closed Access | Times Cited: 3
Seagrass as a potential nutraceutical to decrease pro-inflammatory markers
Vani Mathakala, Tejaswini Ullakula, Uma Maheswari Devi Palempalli
BMC Complementary Medicine and Therapies (2024) Vol. 24, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top